Urinary incontinence (leakage) refers to the involuntary loss of urine from the bladder, which constitutes a social or hygienic problem for the individual. Bladder control problems affect about 17 million people in the United States.
Urinary incontinence (leakage) refers to the involuntary loss of urine from the bladder, which constitutes a social or hygienic problem for the individual. Bladder control problems affect about 17 million people in the United States. It can be a cause of anxiety, social embarrassment and may limit ones social and daily activities. Fortunately, most of these conditions can be treated. However the first step to curing this condition is acknowledging the problem and then deciding to see a physician who has been properly trained in treating this condition.
Causes of IncontinenceThere are many causes of urinary incontinence. Some of these causes are related to temporary conditions. Once they are treated, the incontinence usually goes away. Temporary causes include:
Urinary tract infectionConstipationCertain medicationsIncreased dietary intake of caffeine, alcohol, artificial sweeteners and carbonated beverages
Some other causes of incontinence are not temporary. There is, however, treatment available for many of these conditions. Other causes include:
Weakness of the muscles that hold the bladder in placeWeakness of the bladder and or the sphincter musclesOveractive or underactive bladder musclesDecreases in certain hormones, especially estrogenNeurological disorders (ex: Multiple Sclerosis, Parkinson's Disease)
Overflow IncontinenceOverflow incontinence occurs due to an inability to completely empty the bladder. There is a constant or frequent small amount of urine leakage. Essentially, the bladder becomes overfilled and the urine leaks out because the bladder can no longer maintain any more urine. A simple analogy would be like water seeping over the top of a dam because it has met its capacity. Patients may experience:
Frequent night time urinationTaking a long time to urinateDribbling stream with little forceUrinating small amounts and not feeling completely empty afterward
Mixed IncontinenceMany patients have a combination of incontinence types. Especially prevalent are patients with both stress and urge incontinence. These patients experience symptoms of:
Leakage with cough, sneeze and rise of abdomen pressureLeakage which is sudden and with little warningFrequent daytime urinationUrgencyEtc. ……please see above for other symptoms
Fistula IncontinenceA fistula is defined as an abnormal connection between two organs lined with some type of skin. It most commonly forms between the bladder or urethra and the vagina. Though uncommon in developed countries such as the United States it can occur after surgical trauma, pelvic cancer, pelvic radiation therapy and obstetric trauma. Patients may experience.
Continuous urine leakageLeakage with cough, sneezing, or rise of abdominal pressureUncontrollable leakage
Clinical EvaluationAll patients should have a comprehensive history and physical examination, which emphasizes the woman's urogenital tract. A focused physical examination assesses vaginal tissue and neighboring organ support. On a patients' first visit to Dr Miklos' office, some simple, relatively painless tests are conducted and may include the following:
Q-tip test - a moistened Q-tip or cotton swab is inserted into the urethra. The patient is asked to strain and the change in angle of the cotton swab is measured. The change in angle is proportional to the degree of bladder-neck descent on bearing down or Valsalva maneuver. Although this anatomical defect is associated with stress incontinence it is not diagnostic, and may occur in women with uterovaginal relaxation without incontinence.
Uroflowmetry - The patient is asked to urinate over a urine catch, which sits on a scale. This test will measure rate of urination, length of urination and whether the urine stream is continuous or intermittent.
Bladder Scan - Upon completion of the uroflowmetry, an ultrasound is performed just above the pubic hairline. This is a quick, painless test that determines the quantity of urine in the bladder. This is helpful in determining if a person empties the bladder completely when urinating.
Simple Cystometry - The patient is then catheterized and the bladder is filled with sterile water and assessed for bladder spasms and cough or stress incontinence.
Urinalysis - The urine obtained at the time of catheterization is tested for blood and bacterial infection.
The physician may recommend other testing or more sophisticated urodynamics to provide for accurate diagnosis and treatment for particular types of incontinence. Advanced Urodynamic testing is usually performed if the patient is not responding to conservative therapy and/or is considering surgery.
Advanced Urodynamic TestingAdvanced Urodynamic Testing is a series of tests and/or x-rays that give a detailed look at the function of the bladder, urethra and sphincters. This helps to diagnose any problems with storing urine or voiding. Urodynamic testing involves having a small catheter placed in the bladder (via the urethra), the vagina or the rectum. Most patients consider urodynamic testing painless.
A Complex Cystometrogram. The bladder is filled with approximately 10-15 ounces of sterile water. Bladder pressures are recorded to determine whether the patient has spontaneous contractions (bladder spasms). After the filling phase the patient is asked to cough and any urine leakage is recorded. Simultaneous coughing and urine leakage is consistent with stress urinary incontinence.
A Voiding Pressure Study. The final portion of the study involves having the person urinate on a special commode with the catheters still in place.
The entire test takes approximately 20-30 minutes. Other tests such as leak point pressure and urethral closure pressures are also performed during advanced urodynamic testing.
© John Miklos MD ,Neeraj Kohli, MD
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More